ZENVISION PHARMA LLP
Mumbai, Maharashtra
In their own words
Zenvision draws its strength from a pool of extremely competent & experienced team members. Each team including intellectual property, formulation & analytical scientists, regulatory & quality assurance experts, sourcing, and project management works in collaboration to ensure delivering the best quality at defined timelines for the completion of every Formulation Development project. Zenvision Pharma provides expert product development services for both Generic pharmaceuticals and Specialty pharmaceuticals. We assist our clients with the submission of ANDAs and Dossiers through our R&D activities, which range from Product Development to Exhibit batches to the review and Compilation of ANDAs and Dossiers. Zenvision Pharma specializes in product development for both highly regulated markets (the United States and Europe) and semi-regulated markets. We also assist our clients with clinical study design, monitoring, and technical support during the commercialization phase through Analytical Method Development and Validation, Stability Studies, and Analysis. We have a team of experienced and qualified professionals who will always provide the best care to our customers. We provide the most comprehensive one-stop pharmaceutical solution for all your go-to-market needs. Our innovative solutions are backed up by a long history of delivering what our customers need and when they need it. Through Innovative Research, we have been always identifying various novel products with IP strength with the help of the Pharma database. We are continuously filing applications for patents in India and in the USA. As a versatile CRO, we have been able to help our clients address the challenges of innovation and regulatory risk with the ongoing development of Novel or 505(b)(2) new drug candidates. We are able to offer process development, CMC, and pharma covigilance to suit our customers’ needs. Zenvison Pharma is an established and trustworthy CRO with a distinct vertical devoted to developing truly novel or 505(b)(2) formulations. Zenvision has submitted over 40 patent applications (31 India, 9 PCT, 5 USA, 2 EU). Innovative projects are being developed for both regulated markets (the United States and Europe) and ROW markets. Zenvision has developed Platform Technologies to extend the Product Life Cycle for certain off-patent products. Zenvision has unique formulations for unmet medical needs.Capability and knowledge base for handling Cytotoxic, Anti-neoplastic, and Hormones products in addition to regular products.Zenvision has developed products that are potential candidates for 505b2 Zenvision Pharma’s manufacturing facility provides pilot BE manufacturing services, as well as pre-clinical and clinical supplies for NCEs to global markets. Pilot BE Study Batches, Pre-Clinical Batches, Clinical Batches, Commercial Batches Zenvision Pharma provides complete support for Formulation Development from concept to commercialization, Formulation Process Development, Analytical Method Development, Process Optimization, Technology Transfer Zenvision Pharma has extensive experience in the analytical development process. Analytical Method Development, Dissolution Profiling, Stability Studies, Stand-alone Analytical Services. We support with the Technology Transfer – The How, Why & When, Technology Transfer Document, Scale-up Batch Manufacturing, Analytical Method Transfer, Exhibit Batch Manufacturing We have Talented Research Team With Hands-On-Experience For Regulated (Us & Eu) And Semi-Regulated Markets For Specific Dosage Forms, Ultra-Modern Research and Development (R&D) Infrastructure, Professional Resource Management Team, Robust Process & Updated Quality Systems. As our human sustainability pillar, Zenvision Pharma aim’s to maintain and improve our human capital by providing access to educational upgrades, health care benefits, work-life balance, and access to knowledge and skills-based programmes. At Zenvision Pharma, we aim to maintain the capital intact. with the efficient use of our assets to maintain company profitability over time. Our conscious choice and efforts enable us to maintain stable economic growth as one of our key objectives of sustainable development. The quality of growth is as important as much the quantity. Zenvision Pharma strongly believe in maintaining a healthy work environment by keeping multiple AHUs in place and adhering to proper waste water treatment and waste disposal procedures. We are concerned about both the inside and outside health of our surroundings.
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- DPIIT recognition number
- DIPP126554
- CIN
- AAE-2082
- Registered on Startup India
- 2023
- Self-declared stage
- Scaling
Where this is
District
Mumbai
Maharashtra
Startup India records the district. We do not have a street address for this company, and we will not invent one.
No point is drawn, because we do not have one.
Geocode confidence: medium
What we do not know
- no incorporation date
- no funding signal of any kind
- no address beyond the district
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, write to trust@indianstartupmap.com.